Parallel Advisors
COGT icon

Parallel Advisors’s Cogent Biosciences COGT Stock Holding History

Parallel Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.72K Buy
+85
New +$3.14K ﹤0.01% 3558
2026
Q2 		– Sell
-1,024
Closed -$39.4K – 3952
2026
Q1 		$39.4K Buy
+1,024
New +$37.8K ﹤0.01% 2131
2022
Q4 		– Sell
-8
Closed – – 3379
2022
Q3 		$0 Buy
+8
New +$110 ﹤0.01% 3188

Other funds holding COGT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Parallel Advisors's COGT Position: Q3 2026 in Review

Parallel Advisors opened a new position in Cogent Biosciences (COGT) in Q3 2026: 85 shares worth $2.72K. The stake represents ﹤0.01% of the portfolio and ranks #3558 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in COGT as recently as Q1 2026.

Parallel Advisors first reported a position in COGT in Q3 2022 and has held it in 3 quarters since. The position peaked at $39.4K in Q1 2026. 60 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Parallel Advisors held 85 shares of Cogent Biosciences worth $2.72K as of Q3 2026.
  • Cogent Biosciences was a new Parallel Advisors position in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3558 holding.
  • Parallel Advisors first reported a position in Cogent Biosciences in Q3 2022 and has held it in 3 quarters since.
  • Parallel Advisors's Cogent Biosciences position peaked at $39.4K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.